National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022

Dyslipidemia has steadily increased in South Korea over the past two decades, emerging as a major public health concern and key risk factor for cardiovascular disease. Thus, our study aimed to investigate long-term trends in the prevalence, awareness, treatment, and control of dyslipidemia in South Korea, including the COVID-19 pandemic. This study utilized data from nationally representative cross-sectional surveys conducted as part of the Korea National Health and Nutrition Examination Survey from 2005 to 2022, analyzing long-term trends of dyslipidemia among 98,396 individuals aged over 30. Weighted linear and binary logistic regression were performed to calculate the β coefficients, β<sub>diff</sub>, and weighted odds ratios with 95% confidence intervals (CIs). Weighted odds ratios were computed for various socioeconomic groups using aggregated data from 2005 to 2022. The prevalence of dyslipidemia increased from 41.30% (95% CI 40.40-42.21) in 2005-2009 to 48.41% (47.36-49.47) in 2020-2022. Awareness increased from 17.87% (16.75-18.99) to 48.90% (47.34-50.47), treatment from 7.10% (6.39-7.80) to 38.19% (36.61-39.76), and control among prevalence from 6.49% (5.79-7.19) to 31.82% (30.33-33.32). Treatment (β<sub>diff</sub>, 3.94 [1.97-5.92]) and control among prevalence (β<sub>diff</sub>, 3.52 [1.67-5.38]) increased more rapidly during the pandemic. Higher odds of dyslipidemia were associated with male sex, older population, rural residence, high BMI, central adiposity, low education and income levels, smoking, and high-risk alcohol consumption. Lower odds of awareness, treatment, and control among individuals with dyslipidemia were associated with male sex, younger population, rural residence, higher education and income levels, smoking, and high-risk alcohol consumption. Over the past 18 years, the prevalence, awareness, treatment, and control of dyslipidemia have steadily increased, with persistent disparities among socioeconomic groups.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-05-08
DOI
https://doi.org/10.1038/s41598-025-00354-2
Citations
7
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
14.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022

Jaeyu Park, Kyeongmin Lee, Sang Youl Rhee, Hyeseung Lee et al.
7 citations
Scientific Reports
Lipoproteins and Cardiovascular Health
14.04
article

National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022

Jaeyu Park, Kyeongmin Lee, Sang Youl Rhee, Hyeseung Lee, Hyesu Jo, Hayeon Lee, Selin Woo, Dong Keon Yon, Jiyoung Hwang, Lee Smith, Sunyoung Kim, Hyeon Jin Kim, Soeun Kim, Seokjun Kim, Yejun Son, Jiseung Kang
article en
7 citations

Abstract

Dyslipidemia has steadily increased in South Korea over the past two decades, emerging as a major public health concern and key risk factor for cardiovascular disease. Thus, our study aimed to investigate long-term trends in the prevalence, awareness, treatment, and control of dyslipidemia in South Korea, including the COVID-19 pandemic. This study utilized data from nationally representative cross-sectional surveys conducted as part of the Korea National Health and Nutrition Examination Survey from 2005 to 2022, analyzing long-term trends of dyslipidemia among 98,396 individuals aged over 30. Weighted linear and binary logistic regression were performed to calculate the β coefficients, β<sub>diff</sub>, and weighted odds ratios with 95% confidence intervals (CIs). Weighted odds ratios were computed for various socioeconomic groups using aggregated data from 2005 to 2022. The prevalence of dyslipidemia increased from 41.30% (95% CI 40.40-42.21) in 2005-2009 to 48.41% (47.36-49.47) in 2020-2022. Awareness increased from 17.87% (16.75-18.99) to 48.90% (47.34-50.47), treatment from 7.10% (6.39-7.80) to 38.19% (36.61-39.76), and control among prevalence from 6.49% (5.79-7.19) to 31.82% (30.33-33.32). Treatment (β<sub>diff</sub>, 3.94 [1.97-5.92]) and control among prevalence (β<sub>diff</sub>, 3.52 [1.67-5.38]) increased more rapidly during the pandemic. Higher odds of dyslipidemia were associated with male sex, older population, rural residence, high BMI, central adiposity, low education and income levels, smoking, and high-risk alcohol consumption. Lower odds of awareness, treatment, and control among individuals with dyslipidemia were associated with male sex, younger population, rural residence, higher education and income levels, smoking, and high-risk alcohol consumption. Over the past 18 years, the prevalence, awareness, treatment, and control of dyslipidemia have steadily increased, with persistent disparities among socioeconomic groups.

Scientific ReportsVol. 15(1)
Harvard University (US), Korea University (KR), Kyung Hee University (KR), Kyung Hee University Medical Center (KR)
National Research Foundation, National Research Foundation of Korea, Iran Telecommunication Research Center, Ministry of Science and ICT, South Korea, Institute for Information and Communications Technology Promotion
Good health and well-being
Openalex Percentile: Top 1%
Lipoproteins and Cardiovascular Health
14.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.